NSCLC PATIENTS WITH BRAIN METASTASIS

Clinical trials for NSCLC PATIENTS WITH BRAIN METASTASIS explained in plain language.

Never miss a new study

Get alerted when new NSCLC PATIENTS WITH BRAIN METASTASIS trials appear

Sign up with your email to follow new studies for NSCLC PATIENTS WITH BRAIN METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy trial aims to outperform standard for Tough-to-Treat lung cancer brain spread

Disease control Recruiting now

This large, international Phase 3 trial is testing if a new drug combination works better than the current standard treatment for a specific type of advanced lung cancer that has spread to the brain. It will compare furmonertinib (a newer targeted drug) given with standard chemot…

Matched conditions: NSCLC PATIENTS WITH BRAIN METASTASIS

Phase: PHASE3 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 02, 2026 04:12 UTC

NSCLC PATIENTS WITH BRAIN METASTASIS

Get alerted when new NSCLC PATIENTS WITH BRAIN METASTASIS trials appear

New combo therapy trial aims to outperform standard for Tough-to-Treat lung cancer brain spread